PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.35%
Negative revenue growth while RUN stands at 12.90%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
26.53%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
72.87%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
78.67%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
62.22%
Net income growth under 50% of RUN's 460.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
62.30%
EPS growth under 50% of RUN's 456.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
62.30%
Diluted EPS growth under 50% of RUN's 436.85%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.12%
Share reduction more than 1.5x RUN's 1.22%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.34%
Diluted share reduction more than 1.5x RUN's 1.26%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
18.17%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
72.30%
FCF growth under 50% of RUN's 156.78%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
68.63%
10Y revenue/share CAGR under 50% of RUN's 231.43%. Michael Burry would suspect a lasting competitive disadvantage.
54.18%
5Y revenue/share CAGR at 75-90% of RUN's 64.82%. Bill Ackman would encourage strategies to match competitor’s pace.
46.43%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
127.60%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
259.76%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
606.49%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
77.75%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-402.72%
Negative 5Y net income/share CAGR while RUN is 1185.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-448.13%
Negative 3Y CAGR while RUN is 220.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-30.93%
Negative 5Y equity/share growth while RUN is at 72.95%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-47.25%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.59%
AR growth well above RUN's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.44%
Inventory is declining while RUN stands at 18.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-5.33%
Negative asset growth while RUN invests at 4.18%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.21%
We have a declining book value while RUN shows 11.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-12.86%
We’re deleveraging while RUN stands at 3.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-25.47%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-31.19%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.